Patterns and predictors of discontinuation of rhythm-control drug therapy in patients with newly diagnosed atrial fibrillation

Pharmacotherapy

Volumn 29, Issue 12, 2009, Pages 1417-1426

  Kim, Michael H ^a   Klingman, David ^b   Lin, Jay ^c   Battleman, David S ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b IQVIA   (United States)

^c SANOFI   (France)

Author keywords

Arrhythmia; Atrial fibrillation; Drug discontinuation; Managed care; Rhythm control

Indexed keywords

AMIODARONE; ATENOLOL; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; METOPROLOL; MORACIZINE; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BILLING AND CLAIMS; CARDIOMYOPATHY; CARDIOVERSION; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RHYTHM; HEART SINOATRIAL BLOCK; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PAROXYSMAL TACHYCARDIA; PATIENT CARE; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; STROKE; THYROID DISEASE; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COHORT STUDIES; DATABASES, FACTUAL; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 73349089329     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.12.1417     Document Type: Article

References (23)

1. . Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: executive summary-a report of the American College of Cardiology/American Heart Association task force on practice guidelines, and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 2006;48:854-906.
2. . Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention-the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001;285:2370-5.
3. . Miyasaka Y, Barnes ME, Gersh BJ, et al. Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. Am J Cardiol 2008;102:568-72.
4. . Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006;9:348-56.
5. . Roy D, Talajic M, Dorian P, et al, for the Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-20.
6. . Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
7. . Channer KS, Birchall A, Steeds RP, et al. A randomized placebo-controlled trial of pre-treatment and short- or longterm maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. Eur Heart J 2004;25:144-50.
8. . Shiga T, Wakaumi M, Imai T, et al. Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure. Circ J 2002;66:600-4.
9. . Kochiadakis GE, Marketou ME, Igoumenidis NE, et al. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing Clin Electrophysiol 2000;23(11 pt 2):1883-7.
10. . Zimetbaum P, Ho KK, Olshansky B, et al. Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation. Am J Cardiol 2003;91:81-3.
11. . Allen-Ramey FC, Bukstein D, Luskin A, Sajjan SG, Markson LE. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy. J Manag Care Pharm 2006;12:310-21.
12. . MacDougall DA, Feliu AL, Boccuzzi SJ, Lin J. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm 2006;63(20 suppl 6):S5-15.
13. . McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R. Overlap of anxiety and depression in a managed care population: prevalence and association with resource utilization. J Clin Psychiatry 2006;67:1187-93.
14. . Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-90.
15. . U.S. Department of Labor. Consumer price index. Available from http://data.bls.gov/cgi-bin/surveymost?cu. Accessed April 15, 2008.
16. . Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the cardiac arrest study Hamburg). Am Heart J 1994;127(4 pt 2):1139-44.
17. . Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Engl J Med 1989;321(6):386-8.
18. . Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
19. . Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol 2007;18:628-33.
20. . Marshall DA, Levy AR, Vidaillet H, et al. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004;141:653-61.
21. . Yu AP, Yu YF, Nichol MB, Gwadry-Sridhar F. Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence. Clin Ther 2008;30:761-74.
22. . Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, et al. Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin 2008;24:1025-31.
23. . Larsen J, Andersen M, Kragstrup J, Gram LF. High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol 2002;53:375-8.